Tobias Feuchtinger Selected Research

Cytarabine (Cytosar-U)

1/2022

Clofarabine increases the eradication of minimal residual disease of primary B-precursor acute lymphoblastic leukemia compared to high-dose cytarabine without improvement of outcome. Results from the randomized clinical trial 08-09 of the Cooperative Acute Lymphoblastic Leukemia Study Group.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tobias Feuchtinger Research Topics

Disease

18	Neoplasms (Cancer) 02/2024 - 09/2011
13	Infections 01/2022 - 03/2004
12	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2023 - 07/2014
11	Leukemia 11/2023 - 05/2004
8	Virus Diseases (Viral Diseases) 01/2023 - 07/2006
7	Adenoviridae Infections (Adenovirus Infections) 09/2015 - 02/2005
6	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2019 - 05/2004
5	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2020 - 11/2004
4	Residual Neoplasm 12/2022 - 07/2014
3	Viremia 03/2015 - 11/2010
2	Nasopharyngeal Carcinoma 01/2024 - 02/2022
2	Sickle Cell Anemia (Hemoglobin S Disease) 11/2023 - 08/2017
2	Neuroblastoma 10/2023 - 01/2018
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2022 - 01/2022
2	Vomiting 01/2020 - 11/2019
2	Invasive Fungal Infections 07/2017 - 06/2017
2	Inflammation (Inflammations) 10/2014 - 09/2011
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Pathologic Complete Response 10/2023
1	Communicable Diseases (Infectious Diseases) 01/2021
1	Glucocorticoid Receptor Deficiency 01/2020
1	Nausea 11/2019
1	Medulloblastoma 01/2019
1	Cardiotoxicity 01/2019
1	Nijmegen Breakage Syndrome 01/2018
1	Human Influenza (Influenza) 01/2018
1	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (Leukemia, Pre B Cell) 01/2018
1	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2018
1	Cytopenia 01/2018
1	Bone Marrow Failure Disorders 01/2018
1	Neutropenia 06/2017
1	Sepsis (Septicemia) 01/2016
1	Bacteremia 01/2016
1	Bronchiolitis Obliterans Syndrome 08/2015

Drug/Important Bio-Agent (IBA)

7	Antiviral Agents (Antivirals)IBA 01/2019 - 03/2004
6	Chimeric Antigen ReceptorsIBA 02/2024 - 01/2020
5	AntigensIBA 01/2022 - 11/2010
3	Peptides (Polypeptides)IBA 01/2022 - 01/2018
2	CytokinesIBA 11/2023 - 01/2022
2	Interleukin-2 (IL2)IBA 10/2023 - 09/2011
2	venetoclaxIBA 12/2022 - 01/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 01/2019
2	blinatumomabIBA 04/2021 - 07/2014
2	AntiemeticsIBA 01/2020 - 11/2019
2	fosaprepitant FDA Link 01/2020 - 11/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2018
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2010
2	posaconazole FDA Link 07/2017 - 06/2017
2	EpitopesIBA 09/2015 - 02/2010
1	NivolumabIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Fluorouracil (Carac)FDA LinkGeneric 01/2024
1	LigandsIBA 01/2024
1	Cisplatin (Platino)FDA LinkGeneric 01/2024
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 11/2023
1	dinutuximabIBA 10/2023
1	Transcription Factors (Transcription Factor)IBA 01/2023
1	Methylprednisolone FDA LinkGeneric 12/2022
1	ProteomeIBA 12/2022
1	Amsacrine (AMSA)IBA 12/2022
1	ElementsIBA 12/2022
1	Etoposide (VP 16)FDA LinkGeneric 12/2022
1	Interferon-betaIBA 02/2022
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2022
1	Immune Checkpoint ProteinsIBA 01/2022
1	Clofarabine (Clolar)FDA Link 01/2022
1	CC ChemokinesIBA 01/2021
1	Decitabine FDA Link 01/2020
1	GlucocorticoidsIBA 01/2020
1	Vincristine (Oncovin)FDA LinkGeneric 11/2019
1	Asparaginase (Elspar)FDA Link 11/2019
1	Prednisolone (Predate)FDA LinkGeneric 11/2019
1	Dimenhydrinate (DMH)FDA LinkGeneric 11/2019
1	Daunorubicin (Cerubidine)FDA LinkGeneric 01/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interferon-gamma (Interferon, gamma)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 01/2019
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2019
1	Indicators and Reagents (Reagents)IBA 01/2018
1	Peptide LibraryIBA 01/2018
1	DNA Ligase ATPIBA 01/2018
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2017
1	TabletsIBA 07/2017
1	Ferritins (Ferritin)IBA 01/2016
1	Neoplasm Antigens (Tumor Antigens)IBA 05/2015

Therapy/Procedure

19	Stem Cell Transplantation 11/2023 - 03/2004
18	Therapeutics 01/2024 - 03/2004
14	Transplantation 10/2023 - 05/2004
12	Hematopoietic Stem Cell Transplantation 01/2023 - 02/2007
10	Immunotherapy 02/2024 - 03/2015
6	Drug Therapy (Chemotherapy) 12/2022 - 11/2010
2	Induction Chemotherapy 01/2024 - 02/2022
2	Activities of Daily Living (ADL) 03/2022 - 01/2022
2	Haploidentical Transplantation 08/2012 - 08/2010
1	Chemoradiotherapy 01/2024
1	Combination Drug Therapy (Combination Chemotherapy) 12/2022
1	Combined Modality Therapy 02/2022
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Platelet Transfusion (Blood Platelet Transfusions) 01/2018